NARDONE, VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 1.918
EU - Europa 1.841
AS - Asia 360
OC - Oceania 4
AF - Africa 2
Totale 4.125
Nazione #
US - Stati Uniti d'America 1.913
GB - Regno Unito 656
IE - Irlanda 383
CN - Cina 192
IT - Italia 166
SE - Svezia 130
UA - Ucraina 128
RU - Federazione Russa 125
DE - Germania 82
SG - Singapore 69
FR - Francia 63
FI - Finlandia 36
VN - Vietnam 33
TR - Turchia 29
ES - Italia 26
IN - India 25
BE - Belgio 18
IM - Isola di Man 7
IR - Iran 7
AU - Australia 4
CA - Canada 4
RO - Romania 4
MK - Macedonia 3
PL - Polonia 3
AT - Austria 2
BD - Bangladesh 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
NL - Olanda 2
NO - Norvegia 2
AL - Albania 1
GR - Grecia 1
LT - Lituania 1
PA - Panama 1
PK - Pakistan 1
Totale 4.125
Città #
Southend 613
Dublin 376
Fairfield 286
Chandler 169
Ashburn 141
Woodbridge 134
Ann Arbor 133
Wilmington 118
Jacksonville 108
Seattle 102
Houston 93
Menlo Park 88
Cambridge 84
Siena 70
Singapore 55
Beijing 49
New York 48
Princeton 44
Dong Ket 33
Dearborn 30
Fremont 29
Izmir 28
Málaga 26
Nanjing 26
Helsinki 23
Shanghai 22
Brussels 18
Boardman 16
Florence 14
San Mateo 13
Munich 12
Tianjin 11
San Diego 10
Shenyang 10
Nanchang 9
Moscow 8
Douglas 7
Falls Church 7
Hebei 7
Jiaxing 7
Santa Clara 7
Changsha 6
Kunming 6
Zhengzhou 6
Fort Worth 5
Massa 5
Sacramento 5
Zanjan 5
Fuzhou 4
Guangzhou 4
Hangzhou 4
Jinan 4
Phoenix 4
Reggio Calabria 4
Timisoara 4
Buffalo 3
Espoo 3
Henderson 3
Hounslow 3
Lancaster 3
Mumbai 3
Ningbo 3
Redwood City 3
San Vitaliano 3
Skopje 3
Abidjan 2
Bari 2
Bhopal 2
Dallas 2
Delhi 2
Dhaka 2
Duncan 2
Falkenstein 2
Hong Kong 2
Islington 2
Lanzhou 2
London 2
Nardò 2
Oslo 2
Prague 2
Priocca 2
Sezze 2
Taizhou 2
Tehran 2
Turin 2
Vienna 2
Vijayawada 2
Wuhan 2
Adelaide 1
Aigaleo 1
Airdrie 1
Amsterdam 1
Bangalore 1
Borghetto Lodigiano 1
Brainerd 1
Campi Bisenzio 1
Canberra 1
Carraia 1
Caserta 1
Cessaniti 1
Totale 3.238
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 249
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 242
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 216
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 211
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 201
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 185
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 182
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 157
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 155
Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: a case report 154
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 150
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 148
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 147
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 145
null 139
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 134
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 132
null 130
null 126
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 123
null 117
null 116
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis 87
null 82
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 69
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 57
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 56
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 54
In Regard to Kubicek et al. 47
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 47
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 39
Persistent hiccup after chemo-radiotherapy in nasopharyngeal cancer: an atypical side effect? 39
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 36
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 32
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 22
Totale 4.226
Categoria #
all - tutte 12.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020585 0 0 0 0 55 85 82 105 94 83 35 46
2020/2021710 33 77 18 61 54 89 38 92 58 90 26 74
2021/2022415 29 44 32 16 31 25 27 25 30 41 44 71
2022/2023601 29 59 86 71 59 112 19 50 59 33 12 12
2023/2024565 16 10 56 28 17 159 247 3 5 8 2 14
2024/2025254 31 40 124 50 9 0 0 0 0 0 0 0
Totale 4.226